Cancer Organoids as reliable disease models to drive clinical development of novel therapies

被引：2

作者：

Giovanni Blandino ^{[1
]}

Ronit Satchi-Fainaro ^{[2
]}

Ingeborg Tinhofer ^{[3
]}

Giovanni Tonon ^{[4
]}

Sarah C. Heilshorn ^{[5
]}

Yong-Jun Kwon ^{[6
]}

Ana Pestana ^{[3
]}

Carlotta Frascolla ^{[1
]}

Luca Pompili ^{[1
]}

Aurora Puce ^{[7
]}

Sara Iachettini ^{[1
]}

Annalisa Tocci ^{[8
]}

Sofia Karkampouna ^{[9
]}

Marianna Kruithof-de Julio ^{[9
]}

Piera Tocci ^{[10
]}

Nicla Porciello ^{[8
]}

Klizia Maccaroni ^{[7
]}

Daniela Rutigliano ^{[1
]}

Xiling Shen ^{[11
]}

Gennaro Ciliberto ^{[12
]}

机构：

[1] IRCCS Regina Elena National Cancer Institute,Translational Research Unit

[2] Tel Aviv University,Deapartment of Physiology and Pharmacology

[3] Charité University Medicin,Department of Radiooncology and Radiotherapy

[4] IRCCS San Raffaele Scientific Institute,Center of Omics Sciences

[5] Stanford University,Department of Materials Science and Engineering

[6] Luxembourg Institute of Health,Cellular Network and Molecular Therapeutic Target Unit

[7] IRCCS Regina Elena National Cancer Institute,Tumor of Immunology and Immunotherapy Unit

[8] IRCCS Regina Elena National Cancer Institute,Department for BioMedical Research

[9] University of Bern,Unit of Preclinical Models and New Therapeutic Agents

[10] IRCCS Regina Elena National Cancer Institute,GI Medical Oncology

[11] MD Anderson Cancer Center,Scientific Direction

[12] Terasaki Institute of Biomedical Innovation,undefined

[13] IRCCS Regina Elena National Cancer Institute,undefined

来源：

Journal of Experimental & Clinical Cancer Research | / 43卷 / 1期

关键词：

Organoid; Precision medicine; Patient-derived 3D culture model; Targeted therapy; Preclinical models; Cancer spheroid;

D O I：

10.1186/s13046-024-03258-7

中图分类号：

学科分类号：

摘要：

On September 23–24 (2024) the 6th Workshop IRE on Translational Oncology, titled “Cancer Organoids as Reliable Disease Models to Drive Clinical Development of Novel Therapies,” took place at the IRCCS Regina Elena Cancer Institute in Rome. This prominent international conference focused on tumor organoids, bringing together leading experts from around the world.

引用

共 50 条

[41] New therapies for cancer induced bone disease: Clinical perspective
Van Poznak, C.
BONE, 2011, 48 (01) : S10 - S10
[42] Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib
Germa, C.
Miller, M.
Mukhopadhyay, P.
Hewes, B.
Caponigro, G.
Scherer, S. J.
Hirawat, S.
ANNALS OF ONCOLOGY, 2017, 28 (08) : 2021 - 2024
[43] Are the animal models of Parkinson's disease suitable for development of neuroprotective therapies?
Kirik, D.
Ulusoy, A.
JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 63 - 63
[44] The translatability of animal models for clinical development: biomarkers and disease models
Wendler, Alexandra
Wehling, Martin
CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (05) : 601 - 606
[45] Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK
Newell, DR
Searle, KM
Westwood, NB
Burtles, SS
BRITISH JOURNAL OF CANCER, 2003, 89 (03) : 437 - 454
[46] Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK
D R Newell
K M Searle
N B Westwood
S S Burtles
British Journal of Cancer, 2003, 89 : 437 - 454
[47] Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis therapies to target breast cancer metastasis
Yang, Yu-an
Yang, Howard
Hu, Ying
Watson, Peter
Liu, Huaitian
Geiger, Thomas R.
Anver, Miriam R.
Haines, Diana
Martin, Philip
Lee, Maxwell P.
Hunter, Kent W.
Wakefield, Lalage M.
CANCER RESEARCH, 2017, 77
[48] Methods used in clinical development of novel anti-asthma therapies
Diamant, Zuzana
Boot, Diderik
Kamerling, Ingrid
Bjermer, Leif
RESPIRATORY MEDICINE, 2008, 102 (03) : 332 - 338
[49] Development of Novel Therapies for Cardiovascular Diseases by Clinical Application of Basic Research
Satoh, Kimio
CIRCULATION JOURNAL, 2017, 81 (11) : 1557 - 1563
[50] Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management Preface
Ahmad, Aamir
Gadgeel, Shirish M.
LUNG CANCER AND PERSONALIZED MEDICINE: NOVEL THERAPIES AND CLINICAL MANAGEMENT, 2016, 890 : V - VI

← 1 2 3 4 5 →